...
首页> 外文期刊>OncoTargets and therapy >Matched-pair analysis of survival in the patients with T3 laryngeal squamous cell carcinoma treated with supracricoid partial laryngectomy or total laryngectomy
【24h】

Matched-pair analysis of survival in the patients with T3 laryngeal squamous cell carcinoma treated with supracricoid partial laryngectomy or total laryngectomy

机译:舌上部分喉切除术或全喉切除术治疗T3喉鳞状细胞癌患者的配对生存分析

获取原文
           

摘要

Background: The survival outcomes between supracricoid partial laryngectomy (SCPL) and total laryngectomy (TL) were compared in the groups of matched-pair patients with T3 laryngeal squamous cell carcinoma (LSCC). Methods: Patients with T3 LSCC were matched based on prognostic factors. The Kaplan–Meier curve and the Cox proportional hazards model were used for analysis on survival. Results: A total of 212 patients with T3 LSCC were included after matching (106 underwent SCPL and 106 underwent TL). Multivariable analysis showed no differences in overall survival (hazard risk [HR]=1.15; 95% CI: 0.79–1.67; P =0.47), disease-specific survival (HR=1.11; 95% CI: 0.69–1.80; P =0.66), and recurrence-free survival (HR=1.07; 95% CI: 0.68–1.68; P =0.77) between the SCPL group and TL group. Conclusion: SCPL provides reliable therapeutic outcomes and can be used to avoid a TL surgery in some patients with advanced primary laryngeal cancer.
机译:背景:在配对配对的T3喉鳞状细胞癌(LSCC)患者组中比较了弓上部分喉切除术(SCPL)和全喉切除术(TL)之间的生存结果。方法:根据预后因素对T3 LSCC患者进行匹配。 Kaplan-Meier曲线和Cox比例风险模型用于生存分析。结果:匹配后共纳入212例T3 LSCC患者(106例接受了SCPL,106例接受了TL)。多变量分析显示总体生存率无差异(危险风险[HR] = 1.15; 95%CI:0.79–1.67; P = 0.47),疾病特异性生存率(HR = 1.11; 95%CI:0.69-1.80; P = 0.66) )和SCPL组与TL组之间的无复发生存率(HR = 1.07; 95%CI:0.68–1.68; P = 0.77)。结论:SCPL可提供可靠的治疗结果,并可用于某些晚期原发性喉癌患者避免进行TL手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号